August 22, 2017 12:17 AM ET

Biotechnology

Company Overview of Idera Pharmaceuticals, Inc.

Executive Profile

James A. Geraghty J.D.

AgeTotal Calculated CompensationThis person is connected to 11 Board Members in 11 different organizations across 15 different industries.

See Board Relationships
62$137,378

Background

Mr. James A. Geraghty, also known as Jim, J.D., served as an Interim Chief Business Officer of Voyager Therapeutics, Inc. Mr. Geraghty served as Senior Vice President of North America Strategy & Business Development at Sanofi. He worked 20 years at Genzyme Corporation. He is an industry leader with 30 years of strategic and leadership experience, including more than 20 years as a Senior Member of Executive Teams at biotechnology companies developing and commercializing ...

Corporate Headquarters

167 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-679-5500
Fax: 617-679-5592

Board Members Memberships

Chairman
Director
Director
Director
2013-Present
Chairman
2014-Present
Trustee
2014-Present
Independent Director
2015-Present
Chairman of the Board
2016-Present
Director
2017-Present
Director

Education

MS
University of Pennsylvania
BA
Georgetown University
JD
Yale Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$84,500
Total Calculated Compensation$137,378
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Idera Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.